Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Treatment Sequencing in Metastatic Castration-Resistant Prostate Cancer: A Clinical Commentary.

Stein CA.

Clin Genitourin Cancer. 2015 Oct;13(5):407-9. doi: 10.1016/j.clgc.2015.05.005. No abstract available.

PMID:
26119230
2.

Targeting the androgen receptor in metastatic castration-resistant prostate cancer.

Aragon-Ching JB.

Future Oncol. 2014 Feb;10(3):329-32. doi: 10.2217/fon.13.255. No abstract available.

PMID:
24559439
3.

Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?

Taplin ME, Balk SP.

JAMA Oncol. 2015 Aug;1(5):577-9. doi: 10.1001/jamaoncol.2015.1457. No abstract available.

PMID:
26181796
4.

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.

Azad AA, Volik SV, Wyatt AW, Haegert A, Le Bihan S, Bell RH, Anderson SA, McConeghy B, Shukin R, Bazov J, Youngren J, Paris P, Thomas G, Small EJ, Wang Y, Gleave ME, Collins CC, Chi KN.

Clin Cancer Res. 2015 May 15;21(10):2315-24. doi: 10.1158/1078-0432.CCR-14-2666.

5.

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer.

Buttigliero C, Tucci M, Bertaglia V, Vignani F, Bironzo P, Di Maio M, Scagliotti GV.

Cancer Treat Rev. 2015 Dec;41(10):884-92. doi: 10.1016/j.ctrv.2015.08.002. Review.

PMID:
26342718
6.

New treatment options in castration-resistant prostate cancer.

Armstrong AJ.

J Natl Compr Canc Netw. 2015 May;13(5 Suppl):690-3.

PMID:
25995432
7.

Metastasis: Resistance fighters.

Savage N.

Nature. 2015 Dec 17;528(7582):S128-9. doi: 10.1038/528S128a. No abstract available.

PMID:
26672785
8.

Androgen receptors in early and castration resistant prostate cancer: friend or foe?

Pelekanou V, Notas G, Stathopoulos EN, Castanas E, Kampa M.

Hormones (Athens). 2013 Apr-Jun;12(2):224-35. Review. No abstract available.

9.

Emerging mechanisms of enzalutamide resistance in prostate cancer.

Claessens F, Helsen C, Prekovic S, Van den Broeck T, Spans L, Van Poppel H, Joniau S.

Nat Rev Urol. 2014 Dec;11(12):712-6. doi: 10.1038/nrurol.2014.243.

PMID:
25224448
10.
11.

Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer.

van Soest RJ, de Morrée ES, Kweldam CF, de Ridder CM, Wiemer EA, Mathijssen RH, de Wit R, van Weerden WM.

Eur Urol. 2015 Jun;67(6):981-5. doi: 10.1016/j.eururo.2014.11.033.

PMID:
25484141
12.

[ASC-J9 for castration-resistant prostate cancer].

Yamashita S, Arai Y.

Nihon Rinsho. 2014 Dec;72(12):2126-9. Japanese.

PMID:
25518345
13.

Drug therapies for metastatic castration-resistant prostate cancer.

El-Bahesh E, Finianos A, Alfaraj A, Aragon-Ching JB.

Future Oncol. 2015;11(17):2395-403. doi: 10.2217/fon.15.168. Review.

PMID:
26274603
14.

Leading causes of castration-resistant prostate cancer.

Lu M, Lu H, Kong Q.

Expert Rev Anticancer Ther. 2015 Apr;15(4):425-32. doi: 10.1586/14737140.2015.1007957. Review.

PMID:
25645203
16.

Chemotherapy in Prostate Cancer.

Hurwitz M.

Curr Oncol Rep. 2015 Oct;17(10):44. doi: 10.1007/s11912-015-0468-7. Review.

PMID:
26216506
17.

Metastatic castration-resistant prostate cancer: targeting the mechanisms of resistance to abiraterone acetate and enzalutamide.

Modena A, Ciccarese C, Fantinel E, Bimbatti D, Tortora G, Massari F.

Expert Rev Anticancer Ther. 2015;15(9):1037-48. doi: 10.1586/14737140.2015.1063423. Review.

PMID:
26134919
18.

Strategies for targeting the androgen receptor axis in prostate cancer.

Carver BS.

Drug Discov Today. 2014 Sep;19(9):1493-7. doi: 10.1016/j.drudis.2014.07.008. Review.

PMID:
25107669
20.

[Molecular biology of castration-resistant prostate cancer].

Doucet L, Terrisse S, Gauthier H, Pouessel D, Le Maignan C, Teixeira L, Culine S.

Bull Cancer. 2015 Jun;102(6):497-500. doi: 10.1016/j.bulcan.2015.04.014. Review. French.

PMID:
26028493
Items per page

Supplemental Content

Support Center